Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | MGLL | Q99685 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30938434 | 1.00 | LMNA (0.66) | LMNAPOLBALDH1A1MEN1KMT2A | |
| SCHEMBL10713472 | 1.00 | LMNA (0.66) | LMNAPOLBALDH1A1MEN1KMT2A | |
| SCHEMBL27761826 | 0.90 | LMNA (0.74) | LMNAPOLBALDH1A1MGLLNPSR1 | |
| SCHEMBL811116 | 0.85 | ALDH1A1 (0.74) | LMNAPOLBALDH1A1MGLLNPSR1 | |
| SCHEMBL19519472 | 0.85 | ALDH1A1 (0.74) | LMNAPOLBALDH1A1MGLLNPSR1 | |
| SCHEMBL11529345 | 0.85 | LMNA (0.64) | LMNAPOLBALDH1A1MEN1KMT2A | |
| SCHEMBL153548 | 0.83 | LMNA (0.70) | LMNAPOLBALDH1A1MGLLNPSR1 | |
| SCHEMBL18963491 | 0.83 | LMNA (0.70) | LMNAPOLBALDH1A1MGLLNPSR1 | |
| SCHEMBL10290385 | 0.82 | LMNA (0.64) | LMNAPOLBALDH1A1MEN1KMT2A | |
| SCHEMBL118897 | 0.82 | LMNA (0.64) | LMNAPOLBALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260102387-A1 | IMMUNOSUPPRESSIVE COMPOUNDS | UNIV BASEL (CH) | 2026-04-16 | — | — | US | disclosed |
| EP-4594304-A2 | IMMUNOSUPPRESSIVE COMPOUNDS | Universität Basel Vizerektorat Forschung (CH) | 2025-08-06 | — | — | EP | disclosed |
| WO-2024069007-A2 | IMMUNOSUPPRESSIVE COMPOUNDS | UNIVERSITÄT BASEL (CH) | 2024-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260102387-A1 | IMMUNOSUPPRESSIVE COMPOUNDS | CHP1, BRD3, IRF3 | LMNA 3056/4885POLB 864/4885ALDH1A1 4040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.